Merck KGaA (ETR:MRK)
Germany · Delayed Price · Currency is EUR 124.45
-1.10 (-0.88%)
At close: Jan 21, 2026
Merck KGaA Revenue
Merck KGaA had revenue of 5.32B EUR in the quarter ending September 30, 2025, with 0.99% growth. This brings the company's revenue in the last twelve months to 21.27B, up 1.47% year-over-year. In the year 2024, Merck KGaA had annual revenue of 21.16B with 0.78% growth.
Revenue (ttm)
21.27B
Revenue Growth
+1.47%
P/S Ratio
2.54
Revenue / Employee
341.18K
Employees
59,020
Market Cap
54.11B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 21.16B | 163.00M | 0.78% |
| Dec 31, 2023 | 20.99B | -1.24B | -5.57% |
| Dec 31, 2022 | 22.23B | 2.55B | 12.93% |
| Dec 31, 2021 | 19.69B | 2.15B | 12.28% |
| Dec 31, 2020 | 17.53B | 1.38B | 8.56% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bayer Aktiengesellschaft | 45.87B |
| Siemens Healthineers AG | 23.38B |
| Fresenius SE & Co. KGaA | 22.45B |
| Fresenius Medical Care AG | 19.64B |
| Sartorius Aktiengesellschaft | 3.52B |
| Redcare Pharmacy NV | 2.82B |
| Fielmann Group AG | 2.42B |
| Carl Zeiss Meditec AG | 2.23B |
Merck KGaA News
- 11 hours ago - EQS-PVR: Merck KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution - Wallstreet:Online
- 5 days ago - Merck KGaA (MKKGY) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow - Seeking Alpha
- 8 days ago - Merck KGaA (MKKGY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 9 days ago - FDA Accepts New Drug Application for Pimicotinib for the Treatment of Tenosynovial Giant Cell Tumor - Benzinga
- 13 days ago - MilliporeSigma: Curiosity Cub Completes 2025 Tour, Inspiring Future Innovators Through AI - Finanz Nachrichten
- 4 weeks ago - Merck KGaA: Pimicotinib Approved as Systemic Treatment in China for Tenosynovial Giant Cell Tumor - Finanz Nachrichten
- 5 weeks ago - Why Immunome, A Top 3% Stock, Just Rocketed On Its Rivalry With Merck KGaA - Investor's Business Daily
- 5 weeks ago - Thin-Film Electrode Market worth $0.97 billion by 2030 at 11.3%, says MarketsandMarkets™ - Benzinga